Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4F-PCC for Warfarin Reversal in LVAD Patients
NCT03473132Phase 4Unknown
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2018
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor X human in Warfarin reversal, sponsored by Brigham and Women's Hospital. Status: unknown.
02
Drugs
coagulation factor X human
03
Conditions
Warfarin reversal
Beyond the preview
Go deeper on NCT03473132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03473132.